These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Molecular dynamics simulations of valinomycin and its potassium complex in homogeneous solvents. Forester TR; Smith W; Clarke JH Biophys J; 1996 Aug; 71(2):544-53. PubMed ID: 8842194 [TBL] [Abstract][Full Text] [Related]
63. Monolayer characteristics of valinomycin in the presence of various salts in aqueous subphase. Zaitsev SYu ; Zubov VP; Möbius D Biochim Biophys Acta; 1993 Jun; 1148(2):191-6. PubMed ID: 8504113 [TBL] [Abstract][Full Text] [Related]
64. [X-ray analysis of pepsin. VI. Atomic structure of the enzyme at 2-angstrom resolution]. Andreeva NS; Zhdanov AS; Fedorov AA; Gushchina AE; Shutskever NE Mol Biol (Mosk); 1984; 18(2):313-22. PubMed ID: 6425642 [TBL] [Abstract][Full Text] [Related]
65. A small-angle X-ray diffraction study of valinomycin and its potassium isothiocyanate complex in solution. Krigbaum WR; Kuegler FR; Oelschlaeger H Biochemistry; 1972 Nov; 11(24):4548-52. PubMed ID: 4654142 [No Abstract] [Full Text] [Related]
66. Synthesis of lysine-valinomycin by solid-phase segment condensation. Gisin BF; Dhundale AR Int J Pept Protein Res; 1979 Oct; 14(4):356-63. PubMed ID: 521217 [TBL] [Abstract][Full Text] [Related]
67. Raman spectroscopic evidence for two conformations of uncomplexed valinomycin in the solid state. Rothschild KJ; Asher IM; Anastassakis E; Stanley HE Science; 1973 Oct; 182(4110):384-6. PubMed ID: 4755634 [TBL] [Abstract][Full Text] [Related]
68. The crystal and molecular structure of the triclinic and monoclinic forms of valinomycin, C54H90N6O18. Smith GD; Duax WL; Langs DA; DeTitta GT; Edmonds JW; Rohrer DC; Weeks CM J Am Chem Soc; 1975 Dec; 97(25):7242-7. PubMed ID: 1194598 [No Abstract] [Full Text] [Related]
69. Chain phase trajectory of a protein molecule. Viswanadhan VN; Sundaram K Int J Pept Protein Res; 1982 Oct; 20(4):371-9. PubMed ID: 6184326 [No Abstract] [Full Text] [Related]
70. Valinomycin crystal structure determination by direct methods. Duax WL; Hauptman H; Weeks CM; Norton DA Science; 1972 May; 176(4037):911-4. PubMed ID: 5033632 [TBL] [Abstract][Full Text] [Related]
71. Conformation of valinomycin in a triclinic crystal form. Karle IL J Am Chem Soc; 1975 Jul; 97(15):4379-86. PubMed ID: 1141600 [No Abstract] [Full Text] [Related]
72. A hybrid minimal principle for the crystallographic phase problem. Liu X; Su WP Acta Crystallogr A; 2000 Nov; 56(Pt 6):525-8. PubMed ID: 11058837 [TBL] [Abstract][Full Text] [Related]
73. A General Methodology for Automated Solid-Phase Synthesis of Depsides and Depsipeptides. Preparation of a Valinomycin Analogue. Kuisle O; Quiñoá E; Riguera R J Org Chem; 1999 Oct; 64(22):8063-8075. PubMed ID: 11674717 [TBL] [Abstract][Full Text] [Related]
74. Structure analysis of small proteins by electron microscopy: valinomycin, bacitracin and low molecular weight cell growth stimulators. Ottensmeyer FP; Bazett-Jones DP; Hewitt J; Price GB Ultramicroscopy; 1978; 3(3):303-13. PubMed ID: 310598 [TBL] [Abstract][Full Text] [Related]
75. Cyclic peptides. 19. Cation binding of a cyclic dodecapeptide cyclo-(L-Val-Gly-Gly-L-Pro)3 in an aprotic medium. Baron D; Pease LG; Blout ER J Am Chem Soc; 1977 Dec; 99(25):8299-8366. PubMed ID: 925266 [No Abstract] [Full Text] [Related]
76. Ion selectivity of proteins: lessons from molecular dynamics simulations on valinomycin. Eisenman G J Gen Physiol; 2011 Sep; 138(3):375. PubMed ID: 21875983 [No Abstract] [Full Text] [Related]
77. Single-Molecule Electrical Currents Associated with Valinomycin Transport of K Schmeltzer AJ; Harris JM; White HS ACS Nano; 2023 May; 17(9):8829-8836. PubMed ID: 37068060 [TBL] [Abstract][Full Text] [Related]
78. Molecular conformation of a D,L stereoisomeric analogue of valinomycin, cyclo[-(L-Val-L-Hyi-L-Val-D-Hyi)2-(D-Val-L-Hyi-L-Val-D-Hyi)-]. Langs DA; Grochulski P; Duax WL; Pletnev VZ; Ivanov VT Biopolymers; 1991 Mar; 31(4):417-23. PubMed ID: 1863693 [TBL] [Abstract][Full Text] [Related]
79. Molecular structure of cyclo[-(D-Val-L-Hyi-L-Val-D-Hyi)2-] revealed by x-ray analysis. Grochulski P; Smith GD; Langs DA; Duax WL; Pletnev VZ; Ivanov VT Biopolymers; 1992 Jul; 32(7):757-64. PubMed ID: 1391629 [TBL] [Abstract][Full Text] [Related]
80. Crystal and molecular structure of the centrosymmetric meso-valinomycin analogue--cyclo (D-Val-D-Hyi-D-Val-L-Hyi-L-Val-D-Hyi-L-Val-L-Hyi-L-Val-D-Hyi-D-Val-L-Hy i) (C60H102N6O18). Pletnev VZ; Fonarev YuD ; Tsygannik IN; Ivanov VT; Pletnev SV; Langs DA; Duax WL Biopolymers; 1995 Nov; 36(5):615-21. PubMed ID: 7578953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]